Brookdale Senior Living Inc (BKD)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Brookdale Senior Living Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 14.40 $ — 75% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AAQS
0/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% -3.3%
- Exp. sales growth 3Y > 5% -0.8%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% -0.8%
- Net debt < 4x EBIT 371.9x
- EBIT positive, 10Y straight 3
- Max. EBIT decline < 50% 63.1%
- Return on equity > 15% –
- ROCE > 15% 0.3%
- Expected return > 10% -0.4%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
2 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 4.4% failed
- More than 10% revenue growth is expected for the coming year 3.6% failed
- Share count grows by less than 3% a year 7.2% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 5.3% failed
- Gross margin at 40% or higher and without meaningful erosion 20.6% failed
- Goodwill from acquisitions does not grow faster than revenue 0.5% passed
- Net debt below twice EBITDA 18.4 x EBITDA failed
- Operating cash flow covers the profits of the last three years 1,201 m passed
- Return on capital at 15% or higher, or up versus two years ago 0.3% failed
- Insiders hold at least 10% or are net buyers 2.0% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 36.0% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.62 | -0.62 – -0.62 | 2,970 | 16.8% | 1 |
| 12/31/2027 | 0.21 | 0.17 – 0.24 | 3,073 | 133.2% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.04 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.37 | – | 747 | 3.90 | -11.20 | 45 | -5 |
| 2025: Q1 | -0.28 | – | 780 | 4.40 | -8.30 | 23 | -18 |
| 2025: Q2 | -0.18 | – | 813 | 9.50 | -5.30 | 84 | 29 |
| 2025: Q3 | -0.49 | – | 778 | 4.20 | -14.70 | 77 | 35 |
| 2025: Q4 | -0.17 | – | 754 | 1.00 | -5.30 | 35 | -29 |
| 2026: Q1 | -0.03 | – | 765 | -2.00 | -0.90 | 21 | -26 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 4,239 | -31 | -404 | -2.18 | 366 | 2,078 | 9,218 |
| 2017 | 3,856 | -270 | -571 | -3.07 | 367 | 1,530 | 7,675 |
| 2018 | 3,521 | -594 | -528 | -2.82 | 204 | 1,018 | 6,467 |
| 2019 | 4,057 | -45 | -268 | -1.44 | 216 | 696 | 7,194 |
| 2020 | 3,023 | -98 | 82 | 0.44 | 206 | 800 | 6,902 |
| 2021 | 2,746 | -217 | -99 | -0.54 | -95 | 697 | 6,410 |
| 2022 | 2,745 | -43 | -238 | -1.25 | 3 | 583 | 5,937 |
| 2023 | 2,867 | 18 | -189 | -0.84 | 163 | 404 | 5,573 |
| 2024 | 2,983 | 47 | -202 | -0.89 | 166 | 212 | 6,336 |
| 2025 | 3,125 | 17 | -263 | -1.12 | 218 | -45 | 5,952 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Brookdale Senior Living Inc. besitzt, verwaltet und betreibt Seniorenwohnanlagen in den USA.
| Employees | 22,440 |
|---|---|
| Headquarters | Brentwood, TN |
| Address | 105 Westwood Place, 37027 Brentwood, United States |
| Phone | 615 221 2250 |
| Website | brookdale.com |
| IPO Date | 22. Nov 2005 |
| ISIN | US1124631045 |
| Stock Split | 5:6 on 04/08/2015 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Nikolas W. Stengle | CEO & Director | 1977 |
| Dawn L. Kussow CPA | Executive VP & CFO | 1974 |
| Chad C. White | Executive VP, General Counsel & Secretary | 1975 |
| Jaclyn C. Pritchett | Executive VP & Chief Human Resources Officer | 1985 |
| Tara Jones | Senior VP & Chief Information Officer | – |
| Michael Grant | Vice President of Investor Relations | – |
| David Cygan | Chief Marketing Officer | – |
| Teddy Hillard | Senior Vice President of Corporate Development | – |
| Margaret Cabell | Chief Sales Officer | – |
| Clark Jones | Senior Vice President of Strategic Operations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Winkle C Christian | Director | Other | 6,729 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.